Published in J Med Virol on July 01, 2007
Reverse transcriptase inhibitors as potential colorectal microbicides. Antimicrob Agents Chemother (2009) 1.26
Surveillance of HIV drug resistance in children receiving antiretroviral therapy: a pilot study of the World Health Organization's generic protocol in Maputo, Mozambique. Clin Infect Dis (2012) 0.95
Long-term virologic response and genotypic resistance mutations in HIV-1 infected Kenyan children on combination antiretroviral therapy. J Acquir Immune Defic Syndr (2013) 0.91
It is time to consider third-line options in antiretroviral-experienced paediatric patients? J Int AIDS Soc (2011) 0.89
HIV-1 subtype and viral tropism determination for evaluating antiretroviral therapy options: an analysis of archived Kenyan blood samples. BMC Infect Dis (2009) 0.89
Analysis of drug resistance in children receiving antiretroviral therapy for treatment of HIV-1 infection in Uganda. AIDS Res Hum Retroviruses (2010) 0.87
High rates of virological failure and drug resistance in perinatally HIV-1-infected children and adolescents receiving lifelong antiretroviral therapy in routine clinics in Togo. J Int AIDS Soc (2016) 0.82
HIV-1 drug resistance-associated mutations among HIV-1 infected drug-naïve antenatal clinic attendees in rural Kenya. BMC Infect Dis (2013) 0.80
High levels of virological failure with major genotypic resistance mutations in HIV-1-infected children after 5 years of care according to WHO-recommended 1st-line and 2nd-line antiretroviral regimens in the Central African Republic: A cross-sectional study. Medicine (Baltimore) (2017) 0.75
Comparison of HIV-1 nef and gag Variations and Host HLA Characteristics as Determinants of Disease Progression among HIV-1 Vertically Infected Kenyan Children. PLoS One (2015) 0.75
HIV-1 protease inhibitor drug resistance in Kenyan antiretroviral treatment-naive and -experienced injection drug users and non-drug users. AIDS Res Ther (2015) 0.75
Potent inhibition of HIV-1 replication by novel non-peptidyl small molecule inhibitors of protease dimerization. J Biol Chem (2007) 1.79
A new subtype (subgenotype) Ac (A3) of hepatitis B virus and recombination between genotypes A and E in Cameroon. J Gen Virol (2005) 1.71
Maximal HIV-1 replication in alveolar macrophages during tuberculosis requires both lymphocyte contact and cytokines. J Exp Med (2002) 1.43
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study. J Am Acad Dermatol (2002) 1.43
Breast-feeding and human immunodeficiency virus infection: assessment of knowledge among clinicians in Kenya. Int J Nurs Pract (2013) 1.38
Human papillomavirus infection and cervical abnormalities in Nairobi, Kenya, an area with a high prevalence of human immunodeficiency virus infection. J Med Virol (2008) 1.35
A single amino acid of the human immunodeficiency virus type 2 capsid affects its replication in the presence of cynomolgus monkey and human TRIM5alphas. J Virol (2007) 1.32
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol (2004) 1.31
Possible role of dimerization in human immunodeficiency virus type 1 genome RNA packaging. J Virol (2003) 1.22
A natural inter-genotypic (2b/1b) recombinant of hepatitis C virus in the Philippines. J Med Virol (2006) 1.21
Viral coinfections among African children infected with human immunodeficiency virus type 1. Clin Infect Dis (2003) 1.18
The use of short-course zidovudine to prevent perinatal transmission of human immunodeficiency virus in rural Kenya. Am J Trop Med Hyg (2003) 1.16
Anti-retroviral activity of TRIM5 alpha. Rev Med Virol (2010) 1.15
Molecular characterization of human immunodeficiency virus type 1 (HIV-1) and HIV-2 in Yaounde, Cameroon: evidence of major drug resistance mutations in newly diagnosed patients infected with subtypes other than subtype B. J Clin Microbiol (2007) 1.14
HLA-Cw*04 allele associated with nevirapine-induced rash in HIV-infected Thai patients. AIDS Res Ther (2009) 1.08
Dissociation of genome dimerization from packaging functions and virion maturation of human immunodeficiency virus type 1. J Virol (2002) 1.06
Correlates of delayed disease progression in HIV-1-infected Kenyan children. J Immunol (2005) 1.05
Improved capacity of a monkey-tropic HIV-1 derivative to replicate in cynomolgus monkeys with minimal modifications. Microbes Infect (2010) 1.05
Effects of CYP2B6 G516T polymorphisms on plasma efavirenz and nevirapine levels when co-administered with rifampicin in HIV/TB co-infected Thai adults. AIDS Res Ther (2010) 1.04
A CCR2-V64I polymorphism affects stability of CCR2A isoform. AIDS (2004) 1.03
Group and individual cognitive-behavioral therapy for childhood anxiety disorders: a randomized trial. J Am Acad Child Adolesc Psychiatry (2002) 1.03
Comparison of anti-viral activity of rhesus monkey and cynomolgus monkey TRIM5alphas against human immunodeficiency virus type 2 infection. Virology (2008) 1.01
Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens. Arch Dermatol (2002) 1.01
Genetic diversity of HIV type 1 in rural eastern Cameroon. J Acquir Immune Defic Syndr (2004) 1.00
Emergence of antiretroviral therapy resistance-associated primary mutations among drug-naive HIV-1-infected individuals in rural western Cameroon. J Acquir Immune Defic Syndr (2006) 1.00
Contribution of RING domain to retrovirus restriction by TRIM5alpha depends on combination of host and virus. Virology (2010) 0.99
Influence of glycosylation on the efficacy of an Env-based vaccine against simian immunodeficiency virus SIVmac239 in a macaque AIDS model. J Virol (2005) 0.98
Minimal region sufficient for genome dimerization in the human immunodeficiency virus type 1 virion and its potential roles in the early stages of viral replication. J Virol (2007) 0.97
Multiple sites in the N-terminal half of simian immunodeficiency virus capsid protein contribute to evasion from rhesus monkey TRIM5α-mediated restriction. Retrovirology (2010) 0.97
Protective effect of interleukin-4 -589T polymorphism on human immunodeficiency virus type 1 disease progression: relationship with virus load. J Infect Dis (2002) 0.97
RANTES -28G delays and DC-SIGN - 139C enhances AIDS progression in HIV type 1-infected Japanese hemophiliacs. AIDS Res Hum Retroviruses (2007) 0.96
HIV type 1 subtype diversity and drug resistance among HIV type 1-infected Kenyan patients initiating antiretroviral therapy. AIDS Res Hum Retroviruses (2009) 0.96
TRIM5α and Species Tropism of HIV/SIV. Front Microbiol (2012) 0.96
Rapid detection of human immunodeficiency virus type 1 group M by a reverse transcription-loop-mediated isothermal amplification assay. J Virol Methods (2009) 0.96
HIV-2 capsids distinguish high and low virus load patients in a West African community cohort. Vaccine (2010) 0.95
The relationship between HIV-1 genome RNA dimerization, virion maturation and infectivity. Nucleic Acids Res (2010) 0.95
Audit of care for children aged 6 to 59 months admitted with severe malnutrition at kenyatta national hospital, kenya. Int Health (2009) 0.95
Transiently, paralleled upregulation of arginase and nitric oxide synthase and the effect of both enzymes on the pathology of asthma. Am J Physiol Lung Cell Mol Physiol (2007) 0.94
Molecular epidemiology of measles virus in Kenya. J Med Virol (2003) 0.94
The polymorphisms in DC-SIGNR affect susceptibility to HIV type 1 infection. AIDS Res Hum Retroviruses (2007) 0.94
Assessment of knowledge on neonatal resuscitation amongst health care providers in Kenya. Pan Afr Med J (2012) 0.93
Recurrence rate of superficial basal cell carcinoma following successful treatment with imiquimod 5% cream: interim 2-year results from an ongoing 5-year follow-up study in Europe. Eur J Dermatol (2005) 0.93
An epidemic of enterovirus 71 infection among HIV-1-infected orphans in Nairobi. AIDS (2004) 0.93
The post-mortem pathology of HIV-1-infected African children. Ann Trop Paediatr (2002) 0.93
High-risk HPV types in lesions of the uterine cervix of female commercial sex workers in the Philippines. J Med Virol (2009) 0.92
Profile of HIV type 1 infection and genotypic resistance mutations to antiretroviral drugs in treatment-naive HIV type 1-infected individuals in Hai Phong, Viet Nam. AIDS Res Hum Retroviruses (2009) 0.92
Prevalence of HBV infection among different HIV-risk groups in Hai Phong, Vietnam. J Med Virol (2011) 0.92
Characterization of HIV type 1 genotypes and drug resistance mutations among drug-naive HIV type 1-infected patients in Northern Vietnam. AIDS Res Hum Retroviruses (2010) 0.92
The changing trend of HIV type 1 subtypes in Nairobi. AIDS Res Hum Retroviruses (2009) 0.91
Wild type and H43Y variant of human TRIM5alpha show similar anti-human immunodeficiency virus type 1 activity both in vivo and in vitro. Immunogenetics (2007) 0.91
Multiple routes of hepatitis C virus transmission among injection drug users in Hai Phong, Northern Vietnam. J Med Virol (2010) 0.91
A single amino acid substitution of the human immunodeficiency virus type 1 capsid protein affects viral sensitivity to TRIM5 alpha. Retrovirology (2010) 0.91
Retro-transduction by virus pseudotyped with glycoprotein of vesicular stomatitis virus. Virology (2007) 0.91
Evaluating a cognitive behavioral therapy group program for anxious five to seven year old children: a pilot study. Depress Anxiety (2009) 0.89
HIV-1 subtype and viral tropism determination for evaluating antiretroviral therapy options: an analysis of archived Kenyan blood samples. BMC Infect Dis (2009) 0.89
Association of RANTES -403 G/A, -28 C/G and In1.1 T/C polymorphism with HIV-1 transmission and progression among North Indians. J Med Virol (2008) 0.89
Generation of rhesus macaque-tropic HIV-1 clones that are resistant to major anti-HIV-1 restriction factors. J Virol (2013) 0.89
HIV type 1 subtypes among STI patients in Nairobi: a genotypic study based on partial pol gene sequencing. AIDS Res Hum Retroviruses (2006) 0.89
Silencing of tripartite motif protein (TRIM) 5alpha mediated anti-HIV-1 activity by truncated mutant of TRIM5alpha. J Virol Methods (2008) 0.89
HIV type 1 infection in Pygmy hunter gatherers is from contact with Bantu rather than from nonhuman primates. AIDS Res Hum Retroviruses (2003) 0.88
Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia. J Infect Dev Ctries (2013) 0.88
Protective effects of IL4-589T and RANTES-28G on HIV-1 disease progression in infected Thai females. AIDS (2006) 0.88
Impact of novel TRIM5alpha variants, Gly110Arg and G176del, on the anti-HIV-1 activity and the susceptibility to HIV-1 infection. AIDS (2009) 0.88
TIM1 haplotype may control the disease progression to AIDS in a HIV-1-infected female cohort in Thailand. AIDS (2010) 0.88
Gag-CA Q110D mutation elicits TRIM5-independent enhancement of HIV-1mt replication in macaque cells. Microbes Infect (2012) 0.87
A naturally occurring single amino acid substitution in human TRIM5α linker region affects its anti-HIV type 1 activity and susceptibility to HIV type 1 infection. AIDS Res Hum Retroviruses (2013) 0.87
An efficient and versatile mammalian viral vector system for major histocompatibility complex class I/peptide complexes. J Virol (2002) 0.87
Genetic diversity of HIV type 1 in Likasi, southeast of the Democratic Republic of Congo. AIDS Res Hum Retroviruses (2004) 0.87
A single amino acid of human immunodeficiency virus type 2 capsid protein affects conformation of two external loops and viral sensitivity to TRIM5α. PLoS One (2011) 0.87
Role of Human TRIM5α in Intrinsic Immunity. Front Microbiol (2012) 0.86
A proposal for a new HIV-1 DLS structural model. Nucleic Acids Res (2012) 0.86
Molecular genetic diversity of hepatitis B virus in Kenya. Intervirology (2009) 0.86
Geographical, genetic and functional diversity of antiretroviral host factor TRIMCyp in cynomolgus macaque (Macaca fascicularis). J Gen Virol (2011) 0.86
Rapid spread of hepatitis C virus among injecting-drug users in the Philippines: Implications for HIV epidemics. J Med Virol (2005) 0.85
Active generation and selection for HIV intersubtype A/D recombinant forms in a coinfected patient in Kenya. AIDS Res Hum Retroviruses (2004) 0.85
HIV type 1 subtypes in circulation in northern Kenya. AIDS Res Hum Retroviruses (2005) 0.85
Changes in the HIV type 1 envelope gene from non-subtype B HIV type 1-infected children in Kenya. AIDS Res Hum Retroviruses (2009) 0.85